Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Non-genomic signaling of steroid receptors in cancer.
Thiebaut C, Vlaeminck-Guillem V, Trédan O, Poulard C, Le Romancer M. Thiebaut C, et al. Among authors: vlaeminck guillem v. Mol Cell Endocrinol. 2021 Dec 1;538:111453. doi: 10.1016/j.mce.2021.111453. Epub 2021 Sep 11. Mol Cell Endocrinol. 2021. PMID: 34520815 Free article. Review.
The scaffold protein menin is essential for activating the MYC locus and MYC-mediated androgen receptor transcription in androgen receptor-dependent prostate cancer cells.
Luo Y, Vlaeminck-Guillem V, Teinturier R, Abou Ziki R, Bertolino P, Le Romancer M, Zhang CX. Luo Y, et al. Among authors: vlaeminck guillem v. Cancer Commun (Lond). 2021 Dec;41(12):1427-1430. doi: 10.1002/cac2.12217. Epub 2021 Dec 1. Cancer Commun (Lond). 2021. PMID: 34850609 Free PMC article. No abstract available.
Urinary PCA3 score predicts prostate cancer multifocality.
Vlaeminck-Guillem V, Devonec M, Colombel M, Rodriguez-Lafrasse C, Decaussin-Petrucci M, Ruffion A. Vlaeminck-Guillem V, et al. J Urol. 2011 Apr;185(4):1234-9. doi: 10.1016/j.juro.2010.11.072. Epub 2011 Feb 22. J Urol. 2011. PMID: 21334023
Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients.
Maillet D, Allioli N, Peron J, Plesa A, Decaussin-Petrucci M, Tartas S, Ruffion A, Crouzet S, Rimokh R, Gillet PG, Freyer G, Vlaeminck-Guillem V. Maillet D, et al. Eur Urol Oncol. 2021 Aug;4(4):609-617. doi: 10.1016/j.euo.2019.08.010. Epub 2019 Oct 31. Eur Urol Oncol. 2021. PMID: 31676281
Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer.
Maillet D, Allioli N, Péron J, Plesa A, Decaussin-Petrucci M, Tartas S, Sajous C, Ruffion A, Crouzet S, Freyer G, Vlaeminck-Guillem V. Maillet D, et al. Among authors: vlaeminck guillem v. Cancers (Basel). 2021 Nov 29;13(23):6014. doi: 10.3390/cancers13236014. Cancers (Basel). 2021. PMID: 34885125 Free PMC article.
67 results